GlycoMimetics News

GlycoMimetics | SCHEDULE 13G/A: Others

Feb 15 07:40

GlycoMimetics | 8-K: Current report

Feb 15 05:42

GlycoMimetics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Feb 15 05:41

GlycoMimetics | 10-K: FY2024 Annual Report

Feb 14 05:35

GlycoMimetics | 8-K: Current report

Feb 1 06:02

GlycoMimetics | DEFA14A: Others

Jan 13 22:02

GlycoMimetics | 8-K: Current report

Jan 13 22:02

GlycoMimetics | 8-K: Current report

Dec 27, 2024 05:33

GlycoMimetics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Logos Global Management LP(7.8%),Logos Global Management GP LLC(7.8%), etc.

Nov 28, 2024 03:23

GlycoMimetics | 10-Q: Q3 2024 Earnings Report

Nov 14, 2024 05:37

GlycoMimetics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Invus Public Equities, L.P.(3.0%),Invus Public Equities Advisors, LLC(3.0%), etc.

Nov 13, 2024 05:36

GlycoMimetics | DEFA14A: Others

Nov 8, 2024 05:54

GlycoMimetics | 8-K: Current report

Nov 8, 2024 05:49

GlycoMimetics | SC 13G: Statement of acquisition of beneficial ownership by individuals-RA Capital Management, L.P.(9.9%),Peter Kolchinsky(9.9%), etc.

Nov 7, 2024 06:42

GlycoMimetics | SC 13D: Statement of acquisition of beneficial ownership by individuals-Adage Capital Management, L.P.(7.90%),Robert Atchinson(7.90%), etc.

Nov 5, 2024 05:30

GlycoMimetics | SCHEDULE 13G/A: Others

Nov 5, 2024 03:05

GlycoMimetics | DEFA14A: Others

Oct 29, 2024 20:13

GlycoMimetics | 8-K: Current report

Oct 29, 2024 20:13

GlycoMimetics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Invus Public Equities, L.P.(8.2%),Invus Public Equities Advisors, LLC(8.2%), etc.

Aug 16, 2024 05:02

GlycoMimetics | SCHEDULE 13G: Others

Aug 15, 2024 04:19